Rituximab Inferior to Ocrelizumab for MS Relapse ...Middle East

The relapse rate among patients with relapsing-remitting multiple sclerosis who were treated with rituximab was higher than among those treated with ocrelizumab, results of a noninferiority study suggest. Medscape Medical News

Hence then, the article about rituximab inferior to ocrelizumab for ms relapse was published today ( Thursday 29/06/2023 - 10:29 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rituximab Inferior to Ocrelizumab for MS Relapse )

Also on site :

• 30–35 terrorists on radar: Army steps up counterterror ops in J&K; intense vigil amid 'Chillai Kalan'
• Nine Years After Carrie Fisher Died, Billie Lourd Says Mom “Lives on Through Joy” With Kids, Dad Bryan Lourd
• No. 20 Virginia notches first 11-win season by beating 25th-ranked Missouri in the Gator Bowl